A diversified portfolio across clinical stages
Making a positive contribution
We are committed to managing our business in a sustainable way, investing responsibly, and supporting our portfolio companies in making positive contributions to society by developing treatments that will make a difference to the lives of patients and their families.
2025 Annual Report
Our Annual Report and Accounts 2025 provides an overview of our strategy update as we seek to maximise value for shareholders.
02.07.25 |
pdf (6.53Mb)
Download
An expert multi-disciplinary team, attracting world-class talent
We are differentiated by our people, who identify innovative technology and take a commercial approach to building businesses capable of delivering transformational treatments to patients.
